Latest News

Following discussions with NHS England, we have agreed to an extension of the pilot flu vaccination service for children aged 2-3 years, with an increase…

Following the recent announcement of the CPCF 2026/27 funding settlement, we know many of you have questions about what it means in practice for your…

MHRA Class 4 Medicines Defect Notification: Mirtazapine 30mg Tablets (Cadila Pharmaceuticals) Drug alert number: EL(26)A/28 Date issued: 08 June 2026 Cadila Pharmaceuticals Limited has informed…

Community Pharmacy England is pleased to announce that Rahul Sharda, an independent pharmacy owner from Stoke-on-Trent, is the new Regional Representative Committee Member for the…

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the May…

Following the announcement of the 2026/27 negotiations, a Drug Tariff update has been published to base the New Medicine Service (NMS) monthly consultation cap on…

Community Pharmacy England’s webinar on the new funding settlement is now available to watch on-demand....

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) EL(26)A/27 DMRC reference number: DMRC- 39320587 Date issued:…